Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Other financing activities (2018 - 2024)

Catheter Precision (VTAK) has disclosed Other financing activities for 4 consecutive years, with $309000.0 as the latest value for Q2 2024.

  • Quarterly Other financing activities rose 270.72% to $309000.0 in Q2 2024 from the year-ago period, while the trailing twelve-month figure was $949000.0 through Jun 2024, up 170.37% year-over-year, with the annual reading at $640000.0 for FY2023, N/A changed from the prior year.
  • Other financing activities for Q2 2024 was $309000.0 at Catheter Precision, down from $640000.0 in the prior quarter.
  • The five-year high for Other financing activities was $872000.0 in Q3 2022, with the low at -$1.5 million in Q1 2022.
  • Average Other financing activities over 3 years is -$31285.7, with a median of $181000.0 recorded in 2023.
  • The sharpest move saw Other financing activities skyrocketed 65.26% in 2023, then skyrocketed 270.72% in 2024.
  • Over 3 years, Other financing activities stood at $872000.0 in 2022, then dropped by 26.61% to $640000.0 in 2023, then tumbled by 51.72% to $309000.0 in 2024.
  • According to Business Quant data, Other financing activities over the past three periods came in at $309000.0, $640000.0, and -$181000.0 for Q2 2024, Q4 2023, and Q2 2023 respectively.